Skip to main content
. Author manuscript; available in PMC: 2016 Sep 12.
Published in final edited form as: Pancreas. 2014 Nov;43(8):1334–1339. doi: 10.1097/MPA.0000000000000213

TABLE 3.

Secondary Modality Results*

Procedural Experience

DEN (n = 1) SUA (n = 9)

Timing from onset to secondary
  procedure (weeks after primary)
26.3 3.4 ± 0.9
Procedures per patient 1.0 PCD 1.0 surgery
Positive fluid culture 1 6
Complications 0 8

Postprocedure Experience

Before After Before After

TPN 0 0 3 5
IV antibiotic use 0 0 9 9
Vasopressor use 0 0 1 1
Organ failure 0 0 2 5
  Pulmonary 0 0 2 5
  Circulatory 0 0 1 1
  Renal 0 0 1 1
Multiple organ failure 0 0 1 1
ICU LOS, days 0 10.3 ± 3.9
Floor LOS, days 3.0 18.9 ± 5.8
Clinical resolution 1 9
Mortality 0 0
*

P value not calculated for SUA versus DEN as n = 1 in DEN group.

Nine patients had one surgical necrosectomy each.

Versus primary modality.